315 related articles for article (PubMed ID: 36470869)
1. FUNDC1 protects against doxorubicin-induced cardiomyocyte PANoptosis through stabilizing mtDNA via interaction with TUFM.
Bi Y; Xu H; Wang X; Zhu H; Ge J; Ren J; Zhang Y
Cell Death Dis; 2022 Dec; 13(12):1020. PubMed ID: 36470869
[TBL] [Abstract][Full Text] [Related]
2. FUNDC1 alleviates doxorubicin-induced cardiotoxicity by restoring mitochondrial-endoplasmic reticulum contacts and blocked autophagic flux.
He W; Sun Z; Tong G; Zeng L; He W; Chen X; Zhen C; Chen P; Tan N; He P
Theranostics; 2024; 14(9):3719-3738. PubMed ID: 38948070
[No Abstract] [Full Text] [Related]
3. Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.
Xia P; Liu Y; Chen J; Coates S; Liu DX; Cheng Z
J Biol Chem; 2018 Dec; 293(51):19672-19685. PubMed ID: 30361442
[TBL] [Abstract][Full Text] [Related]
4. COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis.
Zhang P; Lu H; Wu Y; Lu D; Li C; Yang X; Chen Z; Qian J; Ge J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373547
[TBL] [Abstract][Full Text] [Related]
5. Mst1 promotes cardiac ischemia-reperfusion injury by inhibiting the ERK-CREB pathway and repressing FUNDC1-mediated mitophagy.
Yu W; Xu M; Zhang T; Zhang Q; Zou C
J Physiol Sci; 2019 Jan; 69(1):113-127. PubMed ID: 29961191
[TBL] [Abstract][Full Text] [Related]
6. Binding of FUN14 Domain Containing 1 With Inositol 1,4,5-Trisphosphate Receptor in Mitochondria-Associated Endoplasmic Reticulum Membranes Maintains Mitochondrial Dynamics and Function in Hearts in Vivo.
Wu S; Lu Q; Wang Q; Ding Y; Ma Z; Mao X; Huang K; Xie Z; Zou MH
Circulation; 2017 Dec; 136(23):2248-2266. PubMed ID: 28942427
[TBL] [Abstract][Full Text] [Related]
7. SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function.
Wang P; Wang L; Lu J; Hu Y; Wang Q; Li Z; Cai S; Liang L; Guo K; Xie J; Wang J; Lan R; Shen J; Liu P
J Mol Cell Cardiol; 2019 Aug; 133():125-137. PubMed ID: 31199952
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycemia-Driven Inhibition of AMP-Activated Protein Kinase α2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes In Vivo.
Wu S; Lu Q; Ding Y; Wu Y; Qiu Y; Wang P; Mao X; Huang K; Xie Z; Zou MH
Circulation; 2019 Apr; 139(16):1913-1936. PubMed ID: 30646747
[TBL] [Abstract][Full Text] [Related]
9. Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission.
Liang X; Wang S; Wang L; Ceylan AF; Ren J; Zhang Y
Pharmacol Res; 2020 Jul; 157():104846. PubMed ID: 32339784
[TBL] [Abstract][Full Text] [Related]
10. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Kininogen-1 aggravates oxidative stress and mitochondrial dysfunction in DOX-induced cardiotoxicity.
Cheng X; Liu D; Song H; Tian X; Yan C; Han Y
Biochem Biophys Res Commun; 2021 Apr; 550():142-150. PubMed ID: 33706097
[TBL] [Abstract][Full Text] [Related]
12. Foxo3a inhibits mitochondrial fission and protects against doxorubicin-induced cardiotoxicity by suppressing MIEF2.
Zhou L; Li R; Liu C; Sun T; Htet Aung LH; Chen C; Gao J; Zhao Y; Wang K
Free Radic Biol Med; 2017 Mar; 104():360-370. PubMed ID: 28137654
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis.
Kitakata H; Endo J; Ikura H; Moriyama H; Shirakawa K; Katsumata Y; Sano M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163335
[TBL] [Abstract][Full Text] [Related]
14. Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes.
Asensio-Lopez MC; Sanchez-Mas J; Pascual-Figal DA; de Torre C; Valdes M; Lax A
Free Radic Biol Med; 2014 Feb; 67():19-29. PubMed ID: 24231192
[TBL] [Abstract][Full Text] [Related]
15. FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis.
Pei Z; Liu Y; Liu S; Jin W; Luo Y; Sun M; Duan Y; Ajoolabady A; Sowers JR; Fang Y; Cao F; Xu H; Bi Y; Wang S; Ren J
Metabolism; 2021 Sep; 122():154840. PubMed ID: 34331963
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-induced cardiomyocyte apoptosis: Role of mitofusin 2.
Tang H; Tao A; Song J; Liu Q; Wang H; Rui T
Int J Biochem Cell Biol; 2017 Jul; 88():55-59. PubMed ID: 28483668
[TBL] [Abstract][Full Text] [Related]
17. Ablation of FUNDC1-dependent mitophagy renders myocardium resistant to paraquat-induced ferroptosis and contractile dysfunction.
Peng H; Fu S; Wang S; Xu H; Dhanasekaran M; Chen H; Shao C; Chen Y; Ren J
Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166448. PubMed ID: 35598771
[TBL] [Abstract][Full Text] [Related]
18. Pentacyclic triterpene oleanolic acid protects against cardiac aging through regulation of mitophagy and mitochondrial integrity.
Gong Y; Luo Y; Liu S; Ma J; Liu F; Fang Y; Cao F; Wang L; Pei Z; Ren J
Biochim Biophys Acta Mol Basis Dis; 2022 Jul; 1868(7):166402. PubMed ID: 35346820
[TBL] [Abstract][Full Text] [Related]
19. TBC1D15 deficiency protects against doxorubicin cardiotoxicity
Yu W; Xu H; Sun Z; Du Y; Sun S; Abudureyimu M; Zhang M; Tao J; Ge J; Ren J; Zhang Y
Acta Pharm Sin B; 2023 Dec; 13(12):4823-4839. PubMed ID: 38045047
[TBL] [Abstract][Full Text] [Related]
20. Bnip3 mediates doxorubicin-induced cardiomyocyte pyroptosis via caspase-3/GSDME.
Zheng X; Zhong T; Ma Y; Wan X; Qin A; Yao B; Zou H; Song Y; Yin D
Life Sci; 2020 Feb; 242():117186. PubMed ID: 31862454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
